ADHD and Methylphenidate Use in Prepubertal Children and BMI and Height at Adulthood.

ABSTRACT:

Importance

As attention-deficit/hyperactivity disorder (ADHD) is commonly diagnosed in childhood, methylphenidate (MPH) is the most widely prescribed treatment. Although effective for symptom management, concerns remain about an association with growth and body composition.

Objective

To investigate the associations of the prevalence of ADHD and MPH use in childhood with body mass index (BMI) and height at adulthood (aged 20 to 25 years).

Design, setting, and participants

In this nationwide retrospective cohort study, data of children aged 6 to 11 years and adolescents aged 12 to 19 years with newly diagnosed ADHD from the Korean National Health Insurance Service were included between January 2008 and December 2013. Exact matched controls of children and adolescents wi

SUBMITTER: Song J 

PROVIDER: S-EPMC12771255 | biostudies-literature | 2026 Jan

REPOSITORIES: biostudies-literature